Bromocriptine-associated ototoxicity [PDF]
The Journal of Laryngology & Otology, 2007 Three patients treated with bromocriptine for chronic hepatic encephalopathy showed audiometric evidence of bilateral sensori-neural hearing-loss. Audiometrically, the hearing improved in all three patients when the bromocriptine dosage was reduced, thus
Ballantyne, J, Lanthier, PL, Morgan, MY
core +6 more sources
Bromocriptine improves glucose tolerance in obese mice via central dopamine D2 receptor-independent mechanism. [PDF]
PLoS ONEBromocriptine, generally regarded as a dopamine D2 receptor agonist, has been used to treat patients with type 2 diabetes in the USA; however, its mechanisms of action including the receptors that mediate its anti-diabetic effects remain unclear ...
Hiroshi Tsuneki +11 more
doaj +2 more sources
Effects of Bromocriptine on Glucose and Insulin Dynamics in Normal and Insulin Dysregulated Horses [PDF]
Frontiers in Veterinary Science, 2022 The objectives of the study were to study the effects of the synthetic ergot alkaloid (EA), bromocriptine, on glucose and lipid metabolism in insulin dysregulated (ID, n = 7) and non-ID (n = 8) mares. Horses were individually housed and fed timothy grass
Caroline M. M. Loos +6 more
doaj +3 more sources
HYPOTHERMIC ACTION OF BROMOCRIPTINE [PDF]
British Journal of Pharmacology, 1975 The body temperature of rats has been studied in a cold environment. In this setting, bromocriptine induced hypothermia. This fall in core temperature was inhibited by pimozide. It was concluded that bromocriptine has a dopamine‐like action in areas of the brain concerned with the control of body temperature, as has previously been shown for ...
D.B. Calne, L.E. Claveria, J.L. Reid
openaire +5 more sources
Surgical Management of Gestational Gigantomastia: A Case Report Highlighting Therapeutic Intervention [PDF]
Plastic and Reconstructive Surgery, Global OpenSummary:. Gigantomastia is an exceedingly rare condition characterized by extraordinary growth of breasts during pregnancy, and its underlying etiology remains elusive.
Misha A. Lemma, MD +4 more
doaj +2 more sources
Study on Synergistic Effect of Bromocriptine and Sitagliptin in Streptozotocin-induced Diabetic Rats [PDF]
Journal of Clinical and Diagnostic Research, 2021 Introduction: Diabetes mellitus is a potentially morbid condition with high prevalence worldwide. Restoration of euglycemia in type 2 diabetes mellitus is difficult to achieve due to its multifactorial pathogenesis and frequently requires multiple ...
Govindaraj Nileshraj +3 more
doaj +1 more source
The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas
BMC Endocrine Disorders, 2021 Background Prolactinoma is a functional pituitary adenoma that secretes excessive prolactin. Dopamine agonists (DAs) such as bromocriptine (BRC) are the first-line treatment for prolactinomas, but the resistance rate is increasing year by year, creating ...
Shuman Wang +6 more
doaj +1 more source
Impact of Nano-Bromocriptine on Egg Production Performance and Prolactin Expression in Layers
Animals, 2021 The current study aimed to investigate the potential use of nano-bromocriptine in improving the laying performance of late laying hens by modulating the prolactin gene expression.
Ahmed Dawod +7 more
doaj +1 more source
Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis
Frontiers in Endocrinology, 2023 ObjectiveBromocriptine treatment has been shown to reduce menstrual bleeding and pain in women with adenomyosis in a pilot clinical trial. The underlying mechanism contributing to the treatment effect is however unknown.
Yiqun Tang +9 more
doaj +1 more source
Bromocriptine in Parkinsonism [PDF]
BMJ, 1974 Bromocriptine, a drug acting directly upon dopaminergic receptors, has been found to have a significant therapeutic action in a double-blind study of 20 patients with idiopathic Parkinsonism who were already receiving conventional therapy, including levodopa.
L. E. Claveria +5 more
openaire +3 more sources